Abstract:New drug development is an extremely time-consuming and high-risk process. [1]It has been widely valued by the biomedical industry to fully explore the new uses of existing drugs and reorientate them. [2]How to find drug disease with potential therapeutic relationship from a large number of unproven relationship pairs is the research focus of drug reorientation. With the help of machine learning model, we can improve the enrichment degree of potential drug disease relationship pairs, and reduce the false positive rate of prediction. In the past few years, a series of graph based convolutional network models have been developed to calculate the information latent feature representation of nodes and links. Researchers at home and abroad have done a lot of research on network embedding technology based on biomedical data, and have achieved a series of important research results. Among them, the research methods used can be divided into two categories: one is the traditional machine learning algorithm based on artificial feature extraction, the other is the method based on deep learning. For example, kipf and welling [3]proposed a new graph convolution network (GCN) with parts of existing models, DeepDR [4] and DTINet [5] based on node characteristics and their connections, which can be used for node classification. Aiming at the problem of imbalance of drug information data samples, the invention provides a drug relocation method based on deep learning multi-source heterogeneous network. In order to avoid the limitations of traditional feature extraction methods, such as highly dependent on the experience and knowledge of medical staff, strong subjectivity, consuming a lot of time and energy to complete, and extracting high-quality features with distinguishing features often exists In this paper, with the help of graph convolution encoder model and variational auto encoder neural network, we can automatically learn the characteristics of multi-source and heterogeneous drug low-dimensional network, and complete the drug relocation of drug disease association prediction.

Understanding Multivariate Drug-Target-DiseaseInterdependence Via Event-Graph.

Drug repurposing based on the DTD-GNN graph neural network: revealing the relationships among drugs, targets and diseases

Gndd: A Graph Neural Network-Based Method For Drug-Disease Association Prediction

An End-to-end Heterogeneous Graph Representation Learning-Based Framework for Drug-Target Interaction Prediction.

Drug repositioning based on weighted local information augmented graph neural network

Prediction of Drug-Disease Associations Based on Multi-Kernel Deep Learning Method in Heterogeneous Graph Embedding

Bi-Level Graph Neural Networks for Drug-Drug Interaction Prediction

Regulation-aware graph learning for drug repositioning over heterogeneous biological network

Multi-Relational Contrastive Learning Graph Neural Network for Drug-Drug Interaction Event Prediction

Drug Repurposing using Consilience of Knowledge Graph Completion Methods

An effective drug-disease associations prediction model based on graphic representation learning over multi-biomolecular network

Heterogeneous multi-scale neighbor topologies enhanced drug-disease association prediction

Multidrug representation learning based on pretraining model and molecular graph for drug interaction and combination prediction

Metapath-aggregated heterogeneous graph neural network for drug-target interaction prediction

Deep learning of multimodal networks with topological regularization for drug repositioning

A general hypergraph learning algorithm for drug multi-task predictions in micro-to-macro biomedical networks

MGRL: Predicting Drug-Disease Associations Based on Multi-Graph Representation Learning

REDDA: Integrating multiple biological relations to heterogeneous graph neural network for drug-disease association prediction

Drug-drug Interaction Prediction with Graph Representation Learning

A Drug Information Embedding Method Based on Graph Convolution Neural Network.

Biomedical knowledge graph learning for drug repurposing by extending guilt-by-association to multiple layers